Objective The purpose of the present study was to evaluate the clinical usefulness of the
delayed post-therapeutic 131 I scan in patients with well-differentiated thyroid cancer by …

This article investigates the association of the time interval between the diagnostic dose and
ablation with the stunning effect, when a 74 MBq 131 I pretherapy scanning was performed …

We performed a prospective random study to assess possible thyroid stunning by a 185-
MBq iodine-131 dose used to diagnose thyroid remnants. Patients with differentiated thyroid …

With regard to the treatment of differentiated non-medullary thyroid carcinoma, there is
controversy over whether radiation from a diagnostic radioiodine (131 I) application really …

Debates regarding thyroid stunning—a phenomenon whereby a diagnostic dose of
radioiodine decreases uptake of a subsequent therapeutic dose by remnant thyroid tissue or …

TO THE EDITOR: From their study of patients referred for radioiodine ablation, Cholewinski
et al.(1) concluded that diagnostic whole-body scanning can be performed effectively with a …

OBJECTIVE Some patients with relapsed differentiated thyroid cancer may show rising
thyroglobulin (Tg) levels despite a lack of 131I uptake on routine whole body imaging. A …

Background Radioiodine remnant ablation (RRA) is used to destroy residual normal thyroid
tissue after total thyroidectomy in differentiated thyroid carcinoma (DTC) patients. As 1850 …

First described by Rawson et al. in 1951, thyroid stunning has become a subject of
considerable controversy. Diagnostic whole body scan (DxWBS) images are usually …

Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcinoma
may be performed using diagnostic imaging with either 123I or 131I. The former is often …